Anaptysbio Inc (ANAB)
Get Email AlertsSector: Pharmaceutical Preparations
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Frazier Healthcare Partners Alan Frazier | 2,316,447 | $231,112 | 42.31% | |
| 2. | Cormorant Asset Management Bihua Chen | 1,135,000 | $113,239 | -8% | 7.36% |
| 3. | Deerfield Management James E. Flynn | 647,466 | $64,598 | +16% | 2.31% |
| 4. | Biotechnology Value Fund / BVF Inc Mark Lampert | 250,265 | $24,969 | -26% | 2.19% |
| 5. | Redmile Group Jeremy Green | 630,250 | $62,880 | +22% | 1.93% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $15.00 | 50,000 | Large Shareholder | 3,033,504 | 2017-01-31 | Filing | |
| $15.00 | 88,709 | Large Shareholder, Director | 297,804 | 2017-01-31 | Filing | |
| $15.00 | 311,291 | Large Shareholder, Director | 1,045,031 | 2017-01-31 | Filing | |
| $15.00 | 16,666 | Director | 287,623 | 2017-01-31 | Filing | |
| $15.00 | 88,709 | Large Shareholder | 88,709 | 2017-01-31 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $72.88 | 8,324 | Officer, Director | 30,064 | 2018-12-12 | Filing | |
| $71.92 | 9,673 | Officer, Director | 38,388 | 2018-12-12 | Filing | |
| $71.11 | 12,003 | Officer, Director | 48,061 | 2018-12-12 | Filing | |
| $70.83 | 4,998 | Officer, Director | 30,064 | 2018-12-11 | Filing | |
| $72.48 | 4,964 | Officer, Director | 35,062 | 2018-12-10 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 33,211 | $3,313 | 3.06% | |
| 2. | 68,000 | $6,784 | 1.43% | |
| 3. | 28,000 | $2,771 | 1.01% | |
| 4. | 262,275 | $26,167 | 0.96% | |
| 5. | 11,823 | $1,180 | 0.9% |
Billionaire Hedge Funds
